Who we are
A Healthcare Focused Private Equity Platform
Parami Partners is a healthcare-focused private equity platform investing in injectables, formulations, and vaccine businesses through control-oriented strategies, combining deep operating expertise with the capital and conviction of seasoned pharmaceutical entrepreneurs.
AUM
$
0
M
CONTROL INVESTMENTS
0
GLOBAL OPERATING SITES
0
REGULATED MARKETS
0
+
What we do
Transforming Complex Pharma Assets
Parami Partners acquires controlling stakes in pharmaceutical and vaccine businesses and drives end-to-end transformation across operations, strategy, and governance.
Our focus is on complex, regulated manufacturing segments – particularly injectables, vaccines and biologics – where operational expertise is critical to value creation
Proven Operational Value Creation
Our investments in Sagent Pharmaceuticals (2023) and Shantha Biologics (April 2024) demonstrate our ability to execute control transactions and lead post-acquisition transformation across manufacturing, portfolio strategy, and commercial operations.